EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:749599 |
| ChEBI Name | abatacept |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Biological Roles: | antiviral agent A substance that destroys or inhibits replication of viruses. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| Applications: | ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. hypoglycemic agent A drug which lowers the blood glucose level. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antipsoriatic A drug used to treat psoriasis. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. anti-inflammatory agent Any compound that has anti-inflammatory effects. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. antirheumatic drug A drug used to treat rheumatoid arthritis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| abatacept (CHEBI:749599) has role anti-anaemic agent (CHEBI:75835) |
| abatacept (CHEBI:749599) has role anti-inflammatory agent (CHEBI:67079) |
| abatacept (CHEBI:749599) has role antihypertensive agent (CHEBI:35674) |
| abatacept (CHEBI:749599) has role antineoplastic agent (CHEBI:35610) |
| abatacept (CHEBI:749599) has role antipsoriatic (CHEBI:50748) |
| abatacept (CHEBI:749599) has role antirheumatic drug (CHEBI:35842) |
| abatacept (CHEBI:749599) has role antiviral agent (CHEBI:22587) |
| abatacept (CHEBI:749599) has role hypoglycemic agent (CHEBI:35526) |
| abatacept (CHEBI:749599) has role immunosuppressive agent (CHEBI:35705) |
| abatacept (CHEBI:749599) has role ophthalmology drug (CHEBI:66981) |
| abatacept (CHEBI:749599) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Abatacept | ChEMBL |
| Abatacept (genetical recombination) | ChEMBL |
| Abatacept recombinant | ChEMBL |
| BMS-188667 | ChEMBL |
| CTLA4-IGG4M | ChEMBL |
| RG-1046 | ChEMBL |
| Brand Names | Source |
|---|---|
| Orencia | ChEMBL |
| Orencia clickject | ChEMBL |